Date: 2013-01-17
Type of information: Clinical research agreement
Compound: early clinical trials
Company: Covance (USA) the Royal Liverpool and Broadgreen University Hospitals NHS Trust (UK)
Therapeutic area:
Type agreement: clinical research
Action mechanism:
Disease:
Details: Covance, a leading global drug development services company, and the Royal Liverpool and Broadgreen University Hospitals NHS Trust (the “Trust”) have entered into a five-year exclusive agreement to work together in conducting early clinical trials at the Royal Liverpool University Hospital on behalf of biotechnology and pharmaceutical companies. The agreement between the Trust and Covance will focus on early phase trials using the clinical research unit at the Royal Liverpool University Hospital.
As part of its 2017 expansion plans, the Trust will look to expand the clinical research unit at the Royal Liverpool University Hospital and further maximize early patient benefits from research at its facility. This expansion will help establish the Royal Liverpool University Hospital and the region as a major biosciences hub. By increasing focus on early clinical research, the Trust will give patients the opportunity to participate in early clinical research for potentially new breakthrough medicines.
Financial terms:
Latest news:
